Resident 360 Study Plans on AMBOSS
Find all Resident 360 study plans on AMBOSS
Fast Facts
A brief refresher with useful tables, figures, and research summaries
Anxiety and Related Disorders
The Diagnostic and Statistical Manual of Mental Disorders, fifth edition (DSM-5) classifies the following types of anxiety disorders:
separation anxiety disorder
selective mutism
specific phobia
social anxiety disorder (social phobia)
panic disorder
agoraphobia
generalized anxiety disorder
substance/medication-induced anxiety disorder
anxiety disorder due to another medical condition
other specified anxiety disorder
unspecified anxiety disorder
Note: Illness anxiety disorder (formerly known as hypochondriasis) was previously listed as an anxiety disorder but has now been classified as a somatic symptom and related disorder in the DSM-5. It is characterized by worrying specifically about having or acquiring a serious medical illness, and individuals may have no or mild somatic symptoms despite the degree of anxiety.
In this section, we focus on the following anxiety disorders:
See the DSM-5-TR for information on other anxiety and related disorders.
Phobias
Phobias are characterized by an immediate and excessive anxiety reaction to a specific object or situation despite the affected person being aware in most cases that the reaction is excessive or unreasonable. Psychotherapeutic intervention with cognitive behavioral therapy (CBT) can help individuals to recognize and control symptoms through both exposure and coping strategies
Social Anxiety Disorder (Social Phobia)
Social phobia is characterized by fear and worry about social situations related to contact with or being scrutinized by others, lasting for 6 months or more. Anxiety-provoking situations may include conversations with new or unfamiliar persons, eating in front of others, or having to speak or perform in public. The fear or anxiety is considered out of proportion to the sociocultural context. Patients with this diagnosis should be evaluated for comorbid conditions (e.g., alcohol or substance use disorders).
Treatment: Selective serotonin-reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs) are first-line treatments for social anxiety disorder. Beta-blockers and monoamine oxidase inhibitors (MAOIs) have shown promise in the treatment of performance anxiety.
Psychotherapeutic interventions focus on analysis of individual perception and interpretation and desensitization techniques and may involve both individual and group therapy.
Psychotherapeutic interventions with CBT may involve both individual and group therapy approaches that focus on analysis and interpretation of perception, desensitization techniques, and coping strategies.
Panic Disorder
Panic disorder is characterized by discrete and brief (often less than 20 minutes) episodes of anxiety and fear accompanied by highly disturbing physical symptoms such as chest pain, shortness of breath, rapid pulse, palpitations, and sweating.
Treatment: Antidepressants are first-line pharmacotherapy for panic disorder and typically involve selective serotonin-reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs). In an acute presentation, where distress or symptoms of anxiety are prominent, benzodiazepines may be useful. Psychotherapeutic intervention with cognitive behavioral therapy can help individuals to recognize and control symptoms through both exposure and coping strategies.
Generalized Anxiety Disorder
Generalized anxiety disorder (GAD) is characterized by chronic worrying that is typically excessive and difficult to control. GAD can manifest in the form of somatic complaints and often coexists with depression.
Diagnosis: According to the DSM-5, all features listed in the following table must be present for at least 6 months to meet the diagnostic criteria for GAD.
DSM-5 Diagnostic Criteria for Generalized Anxiety Disorder |
---|
All the features listed must be present in order to make a diagnosis of generalized anxiety disorder.
|
Screening: Although the recommendations for routine screening for anxiety disorder are controversial, the Generalized Anxiety Disorder-7 (GAD-7) questionnaire can be used to assess the severity of symptoms and response to treatment.
![[Image]](content_item_media_uploads/nejmcp1502514_f1.jpg)
(Source: Generalized Anxiety Disorder. N Engl J Med 2015.)
Management and Treatment: As with treatment of depression, treatment of GAD typically involves psychotherapy, pharmacotherapy, or a combination of the two approaches as described in the following two tables:
![[Image]](content_item_media_uploads/nejmcp1502514_t2.jpg)
(Source: Generalized Anxiety Disorder. N Engl J Med 2015.)
![[Image]](content_item_media_uploads/nejmcp1502514_t3.jpg)
(Source: Generalized Anxiety Disorder. N Engl J Med 2015.)
Research
Landmark clinical trials and other important studies
Carl E et al. Cogn Behav Ther 2020.
A meta-analysis of 79 RCTs reviewing use of psychotherapy and medication in the treatment of GAD
![[Image]](content_item_thumbnails/23337.jpg)
Giampaolo P et al. Int J Mol Sci 2016.
In this systematic review of the use of second-generation antipsychotics in panic disorder, evidence was insufficient to determine the efficacy of second-generation antipsychotics in panic disorder.
![[Image]](content_item_thumbnails/23338.jpg)
Barkowski S et al. J Anxiety Disord 2016.
A meta-analysis of group psychotherapy for adult patients with social anxiety disorder
![[Image]](content_item_thumbnails/23346.jpg)
Steenen SA et al. J Psychopharmacol 2016.
![[Image]](content_item_thumbnails/23341.jpg)
Bandelow B et al. Int Clin Psychopharmacol 2015.
In this meta-analysis of treatment options for anxiety, medication was the most efficacious and psychotherapy was not better than placebo.
![[Image]](content_item_thumbnails/528.jpg)
Mayo-Wilson E et al. Lancet Psychiatry 2014.
A systematic review of the interventions available for the acute treatment of social anxiety disorder
![[Image]](content_item_thumbnails/23345.jpg)
Donovan MR et al. J Affect Disord 2010.
A meta-analysis of 22 studies showed that continuation of antidepressant treatment following an acute response reduced relapse across five types of anxiety disorder, although efficacy for each varied.
![[Image]](content_item_thumbnails/23333.jpg)
Ipser JC et al. Expert Rev Neurother 2008.
![[Image]](content_item_thumbnails/23344.jpg)
Hofmann SG and Smits JA. J Clin Psychiatry 2008.
A review of multiple studies to evaluate the efficacy of CBT in treatment of adult anxiety disorders
![[Image]](content_item_thumbnails/23336.jpg)
Norton PJ and Price EC. J Nerv Ment Dis 2007.
A review of multiple studies to compare treatment outcomes of cognitive behavioral treatment (CBT) across multiple anxiety disorders
![[Image]](content_item_thumbnails/23335.jpg)
Wells A and King P. J Behav Ther Exp Psychiatry 2006.
A study to investigate a new treatment modality for GAD: meta-cognitive therapy
![[Image]](content_item_thumbnails/23330.jpg)
Bakker A et al. Acta Psychiatr Scand 2002.
A meta-analysis of 43 studies comparing SSRIs and TCAs for symptom reduction and tolerability in the treatment of panic disorder
![[Image]](content_item_thumbnails/23339.jpg)
Reviews
The best overviews of the literature on this topic
Garakani et al. Front Psychiatry 2020
![[Image]](content_item_thumbnails/56584.jpg)
Locke AB et al. Am Fam Physician 2015.
![[Image]](content_item_thumbnails/531.jpg)
Stein MB and Sareen J. N Engl J Med 2015.
![[Image]](content_item_thumbnails/530.jpg)
Patel G and Fancher TL. Ann Intern Med 2013.
![[Image]](content_item_thumbnails/3305.jpg)
Katon WJ. N Engl J Med 2006.
![[Image]](content_item_thumbnails/536.jpg)
Schneier FR. N Engl J Med 2006.
![[Image]](content_item_thumbnails/534.jpg)
Guidelines
The current guidelines from the major specialty associations in the field
American Psychiatric Association 2022.
![[Image]](content_item_thumbnails/DSM-5-TR.jpg)
Gautam S et al. Indian J Psychiatry 2017.
![[Image]](content_item_thumbnails/23350.jpg)
Siu AL et al. JAMA 2016.
![[Image]](content_item_thumbnails/jama.2015.18392.jpg)
Stein MB et al. American Psychiatric Association 2010.
![[Image]](content_item_thumbnails/panicdisorder.jpg)